MedPath

Effect of Antigens or Therapeutic Agents on in Vitro Human Intestinal Organoids

Active, not recruiting
Conditions
Intestine Disease
Registration Number
NCT03256266
Lead Sponsor
University of Erlangen-Nürnberg Medical School
Brief Summary

The study evaluates the effect of nutrient antigens or therapeutic agents on human small intestinal organoids.

Detailed Description

Small intestinal biopsies will be taken to establish human intestinal organoids in vitro. The organoids will be propagated and various antigens will be checked for their effects on proliferation, production of inflammatory components or signal cascade.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
375
Inclusion Criteria
  • patients with gastrointestinal disorders and therapeutical indication of gastroduodenoscopy or coloscopy
  • healthy controls for preventive medical check-up
Exclusion Criteria
  • pregnant women

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Determination of proliferation, apoptosis, histology, and cytokine Expression before and after Antigen provocation of organoids with gluten peptides, nutritional Antigens, Glucagon like peptide antagonist, or Tumor nekrose factor antagonistsbaseline vs 24h vs 48h vs 72h

Determination of effects on organoids after antigen Stimulation with ELISA, histochemistry, RNA or proteome analysis

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Department of Medicine 1, Hector Center for Nutrition, Exercise and Sports, Friedrich-Alexander-University Erlangen-Nuremberg

🇩🇪

Erlangen, Germany

© Copyright 2025. All Rights Reserved by MedPath